Literature DB >> 9676300

Aldesleukin therapy in HIV-infected patients.

D J Sundin1, M J Wolin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9676300     DOI: 10.1093/ajhp/55.14.1520

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  5 in total

1.  Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-07-25       Impact factor: 2.046

2.  Proinflammatory Cytokine Infusion Attenuates LH's Feedforward on Testosterone Secretion: Modulation by Age.

Authors:  Johannes Veldhuis; Rebecca Yang; Ferdinand Roelfsema; Paul Takahashi
Journal:  J Clin Endocrinol Metab       Date:  2015-11-24       Impact factor: 5.958

3.  Interleukin-2 drives cortisol secretion in an age-, dose-, and body composition-dependent way.

Authors:  Ferdinand Roelfsema; Peter Y Liu; Rebecca Yang; Paul Takahashi; Johannes D Veldhuis
Journal:  Endocr Connect       Date:  2020-07       Impact factor: 3.335

4.  Interleukin-2 Transiently Inhibits Pulsatile Growth Hormone Secretion in Young but not Older Healthy Men.

Authors:  Ferdinand Roelfsema; Rebecca Yang; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

5.  Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis.

Authors:  Bingyu Xiang; Chunyu Deng; Fei Qiu; Jingjing Li; Shanshan Li; Huifang Zhang; Xiuli Lin; Yukuan Huang; Yijun Zhou; Jianzhong Su; Mingqin Lu; Yunlong Ma
Journal:  J Nanobiotechnology       Date:  2021-12-06       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.